Department of Dermatology

gamma/delta T cells RNA-transfected with a T-cell receptor and a chimeric antigen receptor specific for melanoma (2016) Harrer D, Simon B, Schuler G, Uslu U, Hoyer S, Dörrie J, Schaft N Conference contribution A web-based comprehensive map including regulatory pathways subverted in melanoma that can be visualized, browsed and used for analysing cell line and patient high through put data (2016) Dreyer F, Cantone M, Eberhardt M, Schuler G, Vera J Conference contribution Combining a CAR and a TCR to generate T cells expressing two additional receptors (TETARs) for melanoma immunotherapy (2016) Uslu U, Gerer K, Hoyer S, Schuler G, Dörrie J, Schaft N Conference contribution Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation (2016) Knippertz I, Deinzer A, Dörrie J, Schaft N, Nettelbeck DM, Steinkasserer A Journal article Sequence-function analysis of three T cell receptors targeting the HIV-1 p17 (2016) Mummert C, Hofmann C, Hueckelhoven AG, Bergmann S, Müller-Schmucker S, Harrer EG, Dörrie J, et al. Conference contribution Soluble CD83 inhibits skin inflammation to chemical sensitizers (2016) Mihatsch P, Boyd P, Krzyzak L, Lechmann M, Nicolas J, Mahler V, Steinkasserer A, Vocanson M Conference contribution S100A8 BUT NOT S100A9 LEVEL IS RELATED TO THE EXTENT OF EROSIVE BONE DAMAGE IN PSORIATIC ARTHRITIS PATIENTS (2016) Simon D, Nas K, Faustini F, Kleyer A, Haschka J, Englbrecht M, Hueber A, et al. Conference contribution Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP) (2016) Hassel J, Forschner A, Bluhm L, Heinzerling L, Zimmer L, Utikal J, Kaehler K, et al. Conference contribution Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab (2016) Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, et al. Journal article Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy (2016) Heinzerling L, Ott PA, Hodi FS, Husain AN, Tajmir-Riahi A, Tawbi H, Pauschinger M, et al. Journal article